Leidos is a company that helps other companies and governments with technology and science stuff. They recently announced that they made more money than people expected in the last three months. This made some people who follow the stock market think that the company is doing well, so they changed their predictions about how much the company's stock price will go up or down. Two of those people raised their predictions, which means they think the company's stock price will go up. Read from source...

1. The analysts who raised their forecasts on Leidos following strong earnings are just doing their jobs and adjusting their models to reflect the company's improved performance. However, they are also making some questionable assumptions and generalizations that may not hold true in the long run.
2. The revenue growth of 8% year-over-year is impressive, but it is important to consider that this is largely due to the acquisition of the health and engineering business of Lockheed Martin in January 2024. The integration of this business has gone smoothly so far, but there may be challenges ahead that could impact Leidos' growth rate.
3. The company's adjusted EPS of $2.63 is also noteworthy, but it is skewed by a lower tax rate and share buybacks. While these factors are positive for shareholders in the short term, they may not be sustainable in the future, especially if the company faces increased competition or regulatory scrutiny.
4. Leidos' increased guidance for the fiscal year 2024 is a positive sign, but it is also important to remember that guidance can be changed based on various factors, such as changes in the business environment, customer demand, or mergers and acquisitions. Therefore, it is not a guarantee of future performance.
5. The analysts who raised their price targets on Leidos are doing so based on their own assumptions and models, which may or may not align with the reality of the company's operations and prospects. It is important for investors to do their own due diligence and not rely solely on the opinions of analysts.

The sentiment expressed in this article is positive, as it highlights Leidos' strong earnings and the subsequent positive updates from analysts.

Since Leidos Holdings, Inc LDOS reported better-than-expected second-quarter fiscal 2024 earnings on Tuesday, with revenue growth of 8% year-over-year to $4.13 billion, beating the analyst consensus estimate of $4.06 billion, driven by demand across all customer segments, especially for managed health services. The defense, aviation, information technology, and biomedical research company's adjusted EPS was $2.63, up 46% year over year, beating the analyst consensus estimate of $2.27.